High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
|Articles|February 15, 2019
- LCGC Europe-02-01-2019
- Volume 32
- Issue 2
Vol 32 No 02 LCGC Europe February 2019 Regular Issue PDF
Click the title above to open the LCGC Europe February 2019 regular issue, Vol 32, No 02, in an interactive PDF format.
Advertisement
Articles in this issue
almost 8 years ago
Going Green in Pharmaceutical Analysisalmost 8 years ago
GC×GC: From Research to Routinealmost 8 years ago
The Essential Guide to Optimizing Sensitivity in GC–FID AnalysisAdvertisement
Related to this article
Nano-liquid chromatography-high-resolution tandem mass spectrometry (nano-LC-HRMS/MS) reveals saliva protein shifts before and after multiple sclerosis therapy.
Max Besenhard explains how hybrid mechanistic and machine learning models can make HPLC method development quicker, more robust and ready for autonomous digital twins.
Ultra-high purity BIP® cylinders aim to give analytical laboratories cleaner baselines and lower detection limits
Polymer sorbent and dual microextraction boost gas chromatography with flame ionization detection (GC-FID) pesticide analysis.
Untargeted liquid chromatography–mass spectrometry (LC–MS) ties job stress in workers to plasma lipid changes.
Ultrahigh-pressure liquid chromatography–quadrupole time-of-flight mass spectrometry (UHPLC–QTOF MS) shows diet shapes honeybee metabolic responses to heat.
Advertisement
Advertisement
Trending on LCGC International
1
Industry Roundup: Air Products Advances Gas Chromatography Performance
2
Fast Low-Pressure Chiral GC for Pesticides in Wine
3
Nano-LC-MS/MS Tracks Saliva in Multiple Sclerosis
4
AI/ML Now: Hybrid Machine Learning for Experiment-Efficient HPLC
5